FDA/MDIC Symposium on Computational Modeling and Simulation

Generating Regulatory In Silico Evidence

Co-sponsored by the U.S. Food and Drug Administration

Overview

Agenda

Speakers

Thank you #ModSim2024 Donors

 

From all of us at MDIC, thank you to all the participants, sponsors, speakers, and exhibitors who contributed to the success of the FDA/MDIC Symposium on Computational Modeling and Simulation held April 16-17, 2024. Your unwavering support, eye-opening insights, and active engagement made this event a resounding success.

#ModSim2024 Gallery

Here’s a brief recap of what made #ModSim2024 exceptional:

• Cutting-edge Insights: We explored the nuances of model credibility assessment and effective presentation of computational evidence in regulatory submissions to the FDA. Our expert-led sessions provided invaluable insights into ensuring the highest standards of credibility and reliability for your models.

• Dynamic Discussions: #ModSim2024 brought together dynamic panel discussions that facilitated the exchange of groundbreaking information and ideas. Together, we explored ways to advance computational modeling and simulation for regulatory-grade evidence, setting the stage for transformative advancements in device innovation.

• Real-World Case Studies: Attendees gained valuable insights from in-depth case studies showcasing successful approaches to assessing model credibility. Practical examples helped navigate challenges and leverage opportunities in the computational evidence landscape.

• Exhibition and Poster Sessions: #ModSim2024 featured a rich tapestry of innovation at the poster exhibits. Topics included the latest tools, technologies, and advancements in computational modeling and simulation, showcasing the cutting-edge contributions of industry trailblazers and thought leaders.

• CM&S Pre-symposium Workshop: Participants also had the opportunity to attend a half-day pre-symposium workshop on April 15, featuring training sessions on crucial topics such as the ASME V&V 40-2018 standard and FDA guidance on computational modeling and simulation.

We look forward to continued collaboration and innovation in the future! Stay tuned for more insights and recaps from #ModSim2024.

Additional Inquiries? 

Please contact MDIC staff at CMS@mdic.org